JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 8, 2004; DOI: 10.1124/jpet.104.079079


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.079079v1
313/1/64    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Joshua Rokach
James G. Martin
Qutayba Hamid
William Powell
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almishri, W.
Right arrow Articles by Powell, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almishri, W.
Right arrow Articles by Powell, W.


Received for publication October 15, 2004.
Revised December 1, 2004.
Accepted for publication December 6, 2004.

Effects of prostaglandin D2, 15-deoxy-{Delta}12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats

Wagdi Almishri 1, Chantal Cossette 1, Joshua Rokach 2, James G. Martin 1, Qutayba Hamid 1, William Powell 1*

1 McGill University 2 Florida Institute of Technology

* Address correspondence to: E-mail: william.powell{at}mcgill.ca

Abstract

Prostaglandin (PG) D2 is an arachidonic acid metabolite that is released by allergen-stimulated mast cells. It is a potent in vitro chemoattractant for human eosinophils, acting through the DP2 receptor/CRTH2. Furthermore, there is in vivo evidence that PGD2 contributes to allergen-induced pulmonary eosinophilia via its classic DP1 receptor. The PGD2-derived product 15-deoxy-{Delta}12,14-PGJ2 is widely used as a PPAR{gamma} agonist and has been shown to have anti-inflammatory properties. However, this substance can also activate eosinophils in vitro through the DP2 receptor. The objectives of the present study were to determine whether PGD2 and 15-deoxy-{Delta}12,14-PGJ2 can induce pulmonary eosinophilia and, if so, to examine the relative effects of selective DP1 and DP2 receptor agonists on this response. Brown Norway rats were treated by intratracheal instillation of PGs. Vehicle and 5-oxo-ETE were used as negative and positive controls, respectively. Lung eosinophils were identified by immunostaining of lung sections with an antibody to major basic protein. Both PGD2 and 15-deoxy-{Delta}12,14-PGJ2 induced robust eosinophilic responses that were apparent by 12 h and persisted for at least 48 h. Two selective DP2 receptor agonists, 15R-methyl-PGD2 and 13-14-dihydro-15-keto-PGD2, induced similar responses, the former being more potent than PGD2, whereas the latter was less potent. The selective DP1 receptor agonist BW245C was completely inactive. We conclude that PGD2 and 15-deoxy-{Delta}12,14-PGJ2 induce eosinophil infiltration into the lung through the DP2 receptor. The potent in vitro DP2 receptor agonist 15R-methyl-PGD2 is also very active in vivo and should be a useful tool in examining the role of this receptor.


Key words: 5-Oxo-ETE, CRTH2, DP2 receptor, Inflammation, Lungs, Prostaglandins


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Patel, C. Cossette, J. R. Anumolu, S. Gravel, A. Lesimple, O. A. Mamer, J. Rokach, and W. S. Powell
Structural Requirements for Activation of the 5-Oxo-6E,8Z, 11Z,14Z-eicosatetraenoic Acid (5-Oxo-ETE) Receptor: Identification of a Mead Acid Metabolite with Potent Agonist Activity
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 698 - 707.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Nomiya, M. Okano, T. Fujiwara, M. Maeda, Y. Kimura, K. Kino, M. Yokoyama, H. Hirai, K. Nagata, T. Hara, et al.
CRTH2 Plays an Essential Role in the Pathophysiology of Cry j 1-Induced Pollinosis in Mice
J. Immunol., April 15, 2008; 180(8): 5680 - 5688.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Shiraishi, K. Asano, K. Niimi, K. Fukunaga, M. Wakaki, J. Kagyo, T. Takihara, S. Ueda, T. Nakajima, T. Oguma, et al.
Cyclooxygenase-2/Prostaglandin D2/CRTH2 Pathway Mediates Double-Stranded RNA-Induced Enhancement of Allergic Airway Inflammation
J. Immunol., January 1, 2008; 180(1): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Schratl, J. F. Royer, E. Kostenis, T. Ulven, E. M. Sturm, M. Waldhoer, G. Hoefler, R. Schuligoi, I. Th. Lippe, B. A. Peskar, et al.
The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking
J. Immunol., October 1, 2007; 179(7): 4792 - 4799.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Sandig, J. E. Pease, and I. Sabroe
Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function
J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. P. Mesquita-Santos, A. Vieira-de-Abreu, A. S. Calheiros, I. H. Figueiredo, H. C. Castro-Faria-Neto, P. F. Weller, P. T. Bozza, B. L. Diaz, and C. Bandeira-Melo
Cutting Edge: Prostaglandin D2 Enhances Leukotriene C4 Synthesis by Eosinophils during Allergic Inflammation: Synergistic In Vivo Role of Endogenous Eotaxin
J. Immunol., February 1, 2006; 176(3): 1326 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Xue, S. L. Gyles, F. R. Wettey, L. Gazi, E. Townsend, M. G. Hunter, and R. Pettipher
Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells
J. Immunol., November 15, 2005; 175(10): 6531 - 6536.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.